{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:39:56Z","timestamp":1794037196224,"version":"4.8.0"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,11,13]],"date-time":"2008-11-13T00:00:00Z","timestamp":1226534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:p><jats:bold>Objective\u2002<\/jats:bold> To assess whether use of tranexamic acid is associated with an increased risk of venous thromboembolism (VTE).<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> Nested case\u2013control study.<\/jats:p><jats:p><jats:bold>Setting\u2002<\/jats:bold> Database study using the General Practice Research Database for the years 1992\u20131998.<\/jats:p><jats:p><jats:bold>Population\u2002<\/jats:bold> Women aged 15\u201349 years with a diagnosis of menorrhagia.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Multivariate conditional logistic regression was used to estimate the risk for VTE associated with different drug treatments for menorrhagia, adjusting for confounders.<\/jats:p><jats:p><jats:bold>Main outcome measures\u2002<\/jats:bold> Adjusted odds ratios with 95% CI.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> A total of 134 cases of VTE and 552 matched controls were identified. Recent use of tranexamic acid was scarce, yielding an adjusted odds ratio for VTE of 3.20 (95% CI 0.65\u201315.78). The use of mefenamic acid (OR<jats:sub>adj<\/jats:sub> 5.54 [95% CI 2.13\u201314.40]) or norethisterone (OR<jats:sub>adj<\/jats:sub> 2.41 [95% CI 1.00\u20135.78]) was associated with an increased risk of VTE, as was a recent\u2014in relation to menorrhagia\u2014diagnosis of anaemia or a haemoglobin value &lt;11.5 g\/dl (OR<jats:sub>adj<\/jats:sub> 2.23 [95% CI 1.02\u20134.86]).<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> We found that tranexamic acid was associated with an increased risk of VTE, although the risk estimate did not reach statistical significance. Increased risks of VTE associated with other treatments for menorrhagia were observed. The increased risk of VTE observed with a diagnosis of anaemia\u2014a proxy for more severe menorrhagia\u2014suggests that menorrhagia could be a prothrombotic condition. The observed association between VTE, tranexamic acid and other treatments for menorrhagia may thus partly be explained by confounding by indication. The possibility that menorrhagia is itself a risk factor for VTE merits further investigation.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2008.01926.x","type":"journal-article","created":{"date-parts":[[2008,11,13]],"date-time":"2008-11-13T12:38:22Z","timestamp":1226579902000},"page":"91-97","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case\u2013control study using the General Practice Research Database"],"prefix":"10.1111","volume":"116","author":[{"given":"A","family":"Sundstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Alfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,12,12]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2003.00097.x"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2003.10.003"},{"key":"e_1_2_11_4_2","volume-title":"British National Formulary","year":"2007"},{"key":"e_1_2_11_5_2","volume-title":"Martindale\u2014the Complete Drug Reference","author":"Sweetman SC","year":"2007"},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1063775"},{"key":"e_1_2_11_7_2","first-page":"65","article-title":"Tranexamic acid and thrombosis of the superior longitudinal sinus","volume":"42","author":"Humbert P","year":"1987","journal-title":"Therapie"},{"key":"e_1_2_11_8_2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1742-1241.1989.tb08809.x","article-title":"Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy","volume":"43","author":"Woo KS","year":"1989","journal-title":"Br J Clin Pract"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2002.01607.x"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318032125e"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200611000-00026"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199704000-00026"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2752(1996)17:5<278::AID-MICR8>3.0.CO;2-F"},{"key":"e_1_2_11_14_2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0038-1649475","article-title":"Treatment with tranexamic acid during pregnancy, and the risk of thrombo\u2010embolic complications","volume":"70","author":"Lindoff C","year":"1993","journal-title":"Thromb Haemost"},{"issue":"2","key":"e_1_2_11_15_2","first-page":"S1","article-title":"Treatment of idiopathic menorrhagia with tranexamic acid","volume":"88","author":"Srinil S","year":"2005","journal-title":"J Med Assoc Thai"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000249"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1616122"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00199.x"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.5.686.32205"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00701.x"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/5.6.688"},{"key":"e_1_2_11_22_2","unstructured":"General Practice Notebook\u2014A UK Medical Reference on the World Wide Web [Internet]. Cambridge UK:The Cambridge Institute for Medical Research Haemoglobin reference range. [www.gpnotebook.co.uk\/simplepage.cfm?ID=1026883654]. Accessed 25 May 2008."},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00061.x"},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01496.x"},{"key":"e_1_2_11_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2007.03.012"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02494.x"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2003.09.016"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc4801.099737"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.181424"},{"key":"e_1_2_11_30_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200528090-00005"},{"key":"e_1_2_11_31_2","unstructured":"Defined Daily Dose for Tranexamic Acid.WHO Collaborating Centre for Drug Statistics Methodology. [www.whocc.no\/atcddd\/] Accessed 23 May 2008."},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10266-0"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2008.01926.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2008.01926.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:40:29Z","timestamp":1697406029000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2008.01926.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1111\/j.1471-0528.2008.01926.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2008.01926.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,12]]},"assertion":[{"value":"2008-12-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}